Search research articles
Contact Us
Filters
Showing results (101-110 of 149) with videos related to
Page
of 15
Sort By:
Hemasphere
|
June 15, 2026
EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation
Barbara Eichhorst, Paolo Ghia, Francesc Bosch, et al.
Hematological Oncology
|
June 23, 2017
Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival
Erel Joffe, N Ariela Arad, Osnat Bairey, et al.
Cancer
|
February 21, 2013
Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implications
Tamar Tadmor, Lev Shvidel, Ariel Aviv, et al.
Leukemia & Lymphoma
|
January 29, 2019
The prognostic role of end of treatment FDG-PET-CT in patients with diffuse large B cell lymphoma can be improved by considering it with absolute monocyte count at diagnosis
Raffaella Marcheselli, Antonella Franceschetto, Stefano Sacchi, et al.
Hematological Oncology
|
June 5, 2020
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma
Raffaella Marcheselli, Alessia Bari, Tamar Tadmor, et al.
Anticancer Research
|
November 7, 2018
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel
Michal Inbar, Yair Herishanu, Neta Goldschmidt, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 7, 2020
Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life Study
Efrat Luttwak, Moshe E Gatt, Eyal Lebel, et al.
Annals of Hematology
|
March 21, 2020
Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study
Yael C Cohen, Hila Magen, Noa Lavi, et al.
European Journal of Haematology
|
July 7, 2019
A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain
Tamar Tadmor, Andrei Braester, Dally Najib, et al.
European Journal of Haematology
|
April 2, 2015
Outcomes of light-chain amyloidosis patients treated with first-line bortezomib: a collaborative retrospective multicenter assessment
Moshe E Gatt, Izhar Hardan, Evgeni Chubar, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 149) with videos related to
Sort By:
Page
of 15
Hemasphere
|
June 15, 2026
EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation
Barbara Eichhorst, Paolo Ghia, Francesc Bosch, et al.
Hematological Oncology
|
June 23, 2017
Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival
Erel Joffe, N Ariela Arad, Osnat Bairey, et al.
Cancer
|
February 21, 2013
Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implications
Tamar Tadmor, Lev Shvidel, Ariel Aviv, et al.
Leukemia & Lymphoma
|
January 29, 2019
The prognostic role of end of treatment FDG-PET-CT in patients with diffuse large B cell lymphoma can be improved by considering it with absolute monocyte count at diagnosis
Raffaella Marcheselli, Antonella Franceschetto, Stefano Sacchi, et al.
Hematological Oncology
|
June 5, 2020
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma
Raffaella Marcheselli, Alessia Bari, Tamar Tadmor, et al.
Anticancer Research
|
November 7, 2018
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel
Michal Inbar, Yair Herishanu, Neta Goldschmidt, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 7, 2020
Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life Study
Efrat Luttwak, Moshe E Gatt, Eyal Lebel, et al.
Annals of Hematology
|
March 21, 2020
Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study
Yael C Cohen, Hila Magen, Noa Lavi, et al.
European Journal of Haematology
|
July 7, 2019
A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain
Tamar Tadmor, Andrei Braester, Dally Najib, et al.
European Journal of Haematology
|
April 2, 2015
Outcomes of light-chain amyloidosis patients treated with first-line bortezomib: a collaborative retrospective multicenter assessment
Moshe E Gatt, Izhar Hardan, Evgeni Chubar, et al.
Page
of 15